CLaaS (Core Lab as a Service) is AIML Innovations' next-generation cloud-native infrastructure that transforms how diagnostic and biometric insights are delivered. Powered by proprietary AI signal enhancement and interpretation tools - MaxYield, MaxYield CDS, and CardioYield - CLaaS provides device-agnostic, scalable, and clinically meaningful diagnostics with minimal infrastructure.
It enables fast, low-cost cardiac data interpretation using mobile or wearable sensors, making high-quality diagnostics accessible in settings ranging from elite athletic programs to underserved rural communities.
CLaaS is not a product, but a delivery infrastructure.
Individual Core Labs are purpose-built on top of the CLaaS platform to address specific use cases.
Lorem ipsum dolor sit amet
CLaaS is designed to work across a wide array of consumer and clinical devices. Compatibility is maintained via open API infrastructure and signal normalization.
Examples of supported device types include:
Device compatibility may vary by deployment model. OEM partnerships and new device integrations are actively explored.
Each Core Lab uses the CLaaS delivery infrastructure but is customized by vertical.
CLaaS is expanding to support population-specific diagnostic models tailored to underserved or distinct communities. These include:
CLaaS supports a variety of deployment approaches to accommodate different healthcare infrastructure settings: